Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keigo Kobayashi, Ichiro Nakachi, Akifumi Mitsuishi, Daisuke Arai, Kaori Sakurai, Katsunori Masaki, Atsushi Chiyotani, Hidenori Takahashi, Toshiyuki Tahara, Kenzo Soejima

Research output: Contribution to journalArticle

Original languageEnglish
JournalClinical Lung Cancer
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Keywords

  • Immune-related adverse events
  • Immunotherapy
  • NSCLC
  • PD-1 inhibitors
  • Severe hepatitis

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis : A Case Report. / Kobayashi, Keigo; Nakachi, Ichiro; Mitsuishi, Akifumi; Arai, Daisuke; Sakurai, Kaori; Masaki, Katsunori; Chiyotani, Atsushi; Takahashi, Hidenori; Tahara, Toshiyuki; Soejima, Kenzo.

In: Clinical Lung Cancer, 01.01.2019.

Research output: Contribution to journalArticle

Kobayashi, Keigo ; Nakachi, Ichiro ; Mitsuishi, Akifumi ; Arai, Daisuke ; Sakurai, Kaori ; Masaki, Katsunori ; Chiyotani, Atsushi ; Takahashi, Hidenori ; Tahara, Toshiyuki ; Soejima, Kenzo. / Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis : A Case Report. In: Clinical Lung Cancer. 2019.
@article{ee2f6e66364d4a50bdf79ddf868d0762,
title = "Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report",
keywords = "Immune-related adverse events, Immunotherapy, NSCLC, PD-1 inhibitors, Severe hepatitis",
author = "Keigo Kobayashi and Ichiro Nakachi and Akifumi Mitsuishi and Daisuke Arai and Kaori Sakurai and Katsunori Masaki and Atsushi Chiyotani and Hidenori Takahashi and Toshiyuki Tahara and Kenzo Soejima",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cllc.2019.02.004",
language = "English",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",

}

TY - JOUR

T1 - Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis

T2 - A Case Report

AU - Kobayashi, Keigo

AU - Nakachi, Ichiro

AU - Mitsuishi, Akifumi

AU - Arai, Daisuke

AU - Sakurai, Kaori

AU - Masaki, Katsunori

AU - Chiyotani, Atsushi

AU - Takahashi, Hidenori

AU - Tahara, Toshiyuki

AU - Soejima, Kenzo

PY - 2019/1/1

Y1 - 2019/1/1

KW - Immune-related adverse events

KW - Immunotherapy

KW - NSCLC

KW - PD-1 inhibitors

KW - Severe hepatitis

UR - http://www.scopus.com/inward/record.url?scp=85074683829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074683829&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2019.02.004

DO - 10.1016/j.cllc.2019.02.004

M3 - Article

C2 - 31699508

AN - SCOPUS:85074683829

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

ER -